Yifan Pharmaceutical Co.,Ltd.’s Net Profit Dropped 32.7% in First Three Quarters of 2023

Yifan Pharmaceutical Co.,Ltd. (亿帆医药股份有限公司) (002019.SZ) reported a net profit of 101.1 million yuan in the first three quarters of 2023, down 32.7% year-on-year.

Meanwhile, the company posted 2.9 billion yuan in revenue, up 7.4% year-on-year.

At the end of the reporting period, it had 12.3 billion yuan in total assets and 3.1 billion yuan in total liabilities, with a liability-to-asset ratio of 25%.